Comparative Effects of Phenylbutazone, Naproxen and Flunixin Meglumine on Equine Platelet Aggregation and Platelet Factor 3 Availability in vitro
AUTOR(ES)
Johnstone, I.B.
RESUMO
Nonsteroidal anti-inflammatory drugs are commonly used in the treatment of inflammatory conditions, and have potential value in the treatment of thrombotic disease in the horse. This study compares the potency of three nonsteroidal anti-inflammatory drugs phenylbutazone, naproxen (equiproxen) and flunixin meglumine (banamine) with respect to their effects on equine platelets. Two functional responses of horse platelets were evaluated in vitro: their ability to aggregate and their ability to make available platelet factor 3 procoagulant activity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1235914Documentos Relacionados
- The effect of oral phenylbutazone on whole blood platelet aggregation in the dog.
- Properdin factor D: effects on thrombin-induced platelet aggregation.
- Multicentre trial of naproxen and phenylbutazone in acute gout.
- Effects of meningococcal and Escherichia coli capsular polysaccharides on human and dog platelet aggregation in vitro.
- Double-blind trial of naproxen and phenylbutazone in ankylosing spondylitis.